GT
EDIT icon

Glenmede Trust’s Editas Medicine EDIT Stock Holding History

Glenmede Trust’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,712
Closed -$357K – 1337
2021
Q3 		$357K Buy
+8,712
New +$477K ﹤0.01% 981
2021
Q1 		– Sell
-4,860
Closed -$339K – 1211
2020
Q4 		$339K Sell
4,860
-37
-0.8% -$1.52K ﹤0.01% 935
2020
Q3 		$136K Buy
4,897
+1,714
+54% +$55.8K ﹤0.01% 1097
2020
Q2 		$92K Buy
3,183
+1,256
+65% +$32.8K ﹤0.01% 1174
2020
Q1 		$56K Hold
1,927
– – ﹤0.01% 1639
2019
Q4 		$56K Sell
1,927
-818
-30% -$20.4K ﹤0.01% 1639
2019
Q3 		$61 Buy
2,745
+534
+24% +$13.2K ﹤0.01% 1565
2019
Q2 		$54 Buy
2,211
+466
+27% +$11.1K ﹤0.01% 1644
2019
Q1 		$42 Hold
1,745
– – ﹤0.01% 1757
2018
Q4 		$39 Sell
1,745
-12,205
-87% -$332K ﹤0.01% 1699
2018
Q3 		$443K Sell
13,950
-795
-5% -$25.7K ﹤0.01% 919
2018
Q2 		$529K Buy
14,745
+9,745
+195% +$345K ﹤0.01% 819
2018
Q1 		$153K Hold
5,000
– – ﹤0.01% 1269
2017
Q4 		$153K Buy
+5,000
New +$126K ﹤0.01% 1269

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Glenmede Trust's EDIT Position: Q4 2021 in Review

Glenmede Trust sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 8,712 shares — an estimated $357K sold.

Glenmede Trust first reported a position in EDIT in Q4 2017 and held it in 14 quarters. The position peaked at $529K in Q2 2018. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Glenmede Trust reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Glenmede Trust sold 8,712 Editas Medicine shares in Q4 2021, an estimated $357K.
  • Glenmede Trust first reported a position in Editas Medicine in Q4 2017 and held it in 14 quarters.
  • Glenmede Trust's Editas Medicine position peaked at $529K in Q2 2018.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Glenmede Trust's 13F filing for Q4 2021, filed 15 Feb 2022.